archTIS (ASX:AR9) Strengthens Its Defence Cybersecurity Position With Growing Recurring Revenue

Aditi Sarkar

07 September 2026 12:20 PM AEST

archTIS (ASX:AR9) Strengthens Its Defence Cybersecurity Position With Growing Recurring Revenue

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

archTIS (ASX:AR9) is building a specialised position in data-centric security for defence and government customers.
Recurring revenue growth is improving the predictability of the company's commercial model.
Defence-grade product validation strengthens the case for broader deployment opportunities.
Contract conversion and progress toward positive Operating Cash Flow remain important areas to watch.

archTIS (ASX:AR9) has quietly built one of the more compelling niche stories on the ASX small-cap technology board: data-centric security software sold into defence and government. The company's products, including NC Protect and the Kojensi secure collaboration platform, control access to sensitive information at the file and data level, an area of rising importance as governments tighten information-security requirements. Its FY26 results gave the market fresh reasons to pay attention.

In its results released on 31 July 2026, archTIS reported record pro-forma FY26 contracted sales of A$16.6 million, up 94 per cent on the prior year, and annual Recurring Revenue of A$14.8 million, up 208 per cent. Fourth-quarter revenue reached A$3.5 million, up 92 per cent, at a gross Margin of about 74 per cent. The sharp rise in recurring revenue is significant because it points to a shift toward predictable, subscription-based income, which can improve revenue visibility over time.

Defence validation

The standout operational milestone was a US Department of Defense achievement: archTIS (ASX:AR9) said NC Protect cleared all 60 test cases in the final US DoD Warfighter Command production testing, with no barriers to deployment identified in high-assurance environments. Passing rigorous defence-grade testing is both a technical endorsement and a potential gateway to larger deployments within one of the world's most demanding security customers.

Contract momentum extended beyond the United States. archTIS pointed to a A$3.2 million Kojensi agreement with the Australian Department of Defence commencing 1 July 2026, combining software licensing and development services, and to an initial award of roughly A$416,000 tied to a US and European military alliance, with additional option years valued at around A$805,000. The company has also flagged a US defence proposal potentially worth up to A$15 million annually, underscoring the scale of the opportunities in its pipeline.

Improving financial discipline

Growth has been accompanied by tighter cost control. archTIS (ASX:AR9) reduced quarterly operating expenses by around 11 per cent, though it still reported negative operating cash flow of about A$3.8 million for the fourth quarter, reflecting the Investment required to pursue larger contracts. For a company scaling recurring revenue, the direction of cash burn relative to ARR growth is a key measure of whether the model is approaching self-funding.

Why it matters, risks and catalysts

The investment appeal is exposure to a structural theme, government and defence data security, with validated products, rapidly growing recurring revenue and high gross margins. The risks are typical of defence-focused software minnows: revenue can be lumpy and dependent on the timing of large government contracts, sales cycles are long, and the company remains cash-flow negative, which could necessitate further funding if growth investment outpaces receipts.

Catalysts to watch include conversion of the large US defence proposal and Warfighter testing into deployment revenue, continued growth in annual recurring revenue, expansion of Kojensi within Australian government, and progress toward positive operating cash flow. Any material multi-year contract would strengthen the company's commercial profile.

On balance, archTIS (ASX:AR9) combines a genuine structural tailwind with tangible evidence of traction: record sales, surging recurring revenue and a hard-won defence validation. The company is not yet cash-flow positive, and its results still depend on winning large contracts, but its expanding recurring-revenue base and defence credentials give it a more substantive commercial foundation. The next phase is about converting validation and pipeline into durable, cash-generative revenue.

FAQs

Q: What does archTIS (ASX:AR9) do?

A:It provides data-centric security software for defence, government and other sensitive environments.

Q: What are archTIS's main products?

A:Its key platforms include NC Protect and Kojensi.

Q: Why is defence validation important?

A:It can support broader deployment opportunities with high-security government customers.

Q: What supports archTIS's growth story?

A:Rising recurring revenue, government contracts and a growing defence pipeline are key drivers.

Q: What is a major risk for archTIS?

A:Long government sales cycles and continued negative operating cash flow remain important risks.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.